Can circulating tumor cells predict resistance in Metastatic breast cancer?

Aju Mathew; Adam M. Brufsky; Nancy E. Davidson

doi:10.1158/1078-0432.CCR-14-2967

Can circulating tumor cells predict resistance in Metastatic breast cancer?

Aju Mathew, Adam M. Brufsky, Nancy E. Davidson

School of Medicine

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Circulating tumor cell (CTC) enumeration provides prognostic but not predictive information for chemotherapy in metastatic breast cancer. Because CTC measurement is reproducible and allows molecular profiling, an assay to assess endocrine resistance was developed. Whether this CTC-based assay can be used to reliably select endocrine therapy must be tested.

Original language	English (US)
Pages (from-to)	2421-2423
Number of pages	3
Journal	Clinical Cancer Research
Volume	21
Issue number	11
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-2967
State	Published - Jun 1 2015

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-14-2967

Cite this

@article{f74969b141734d5a9b031b79e5fb7f52,

title = "Can circulating tumor cells predict resistance in Metastatic breast cancer?",

abstract = "Circulating tumor cell (CTC) enumeration provides prognostic but not predictive information for chemotherapy in metastatic breast cancer. Because CTC measurement is reproducible and allows molecular profiling, an assay to assess endocrine resistance was developed. Whether this CTC-based assay can be used to reliably select endocrine therapy must be tested.",

author = "Aju Mathew and Brufsky, {Adam M.} and Davidson, {Nancy E.}",

note = "Publisher Copyright: {\textcopyright} 2015 AACR.",

year = "2015",

month = jun,

day = "1",

doi = "10.1158/1078-0432.CCR-14-2967",

language = "English (US)",

volume = "21",

pages = "2421--2423",

journal = "Clinical Cancer Research",

issn = "1078-0432",